Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Neuromuscul Disord. 2013 Nov 15;24(3):227–240. doi: 10.1016/j.nmd.2013.11.001

Table 6.

Results of validation attempts for predicted novel missplicing events*

Gene Exon In/Out DM1 vs. N DM2 vs. N NMD vs. N Result
ATP9B 8 Out 0.5668 0.3534 0.1657 no difference
9b Out 0.3849 0.4133 0.8619 no difference
11 Out 0.7261 0.6737 0.7798 no difference
BTRC 2a Out 0.9578 0.6980 0.6051 no difference
2a, 2b Out 0.6641 0.5674 0.5452 no difference
2b Out 0.3555 0.6376 0.5807 no difference
CD46 7 In 0.9039 0.8601 0.1370 no difference
IL28RA 2 Out 0.8594 0.6413 0.3470 no difference
MASP1 2a In 0.7558 0.6472 0.1647 no difference
SGCD 2 In 0.6140 0.3070 0.9961 no difference
SMN1 8 In 0.0626 0.9995 0.0738 no difference
SSBP3 6 In 0.0013 0.0035 na DM vs. N significant
STAU 1b In 0.2834 0.6541 na no difference
2b In 0.7469 0.2206 na no difference
TPD52L2 4 In 0.1647 0.0037 0.0051 DM2 vs. N significant
NMD vs. N significant
*

Predicted events with monomorphic/invariant PCR products: ANKD1 (E2), BIN1 (E11), CCNB1IP1 (E5), CTSB (E2b), FGD4 (E6, 14, 18), MKNK1 (E8), SPRY4 (E2), TMC4 (E11), TPM1 (E9b), and YY1AP1 (E4).